Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome

5074 Background: Advanced ovarian cancer remains without chemotherapeutic cure. Numerous regimens can achieve clinical responses, but each only in a subset of women. The challenge is to predict whi...